Baxter International Inc. unveiled multiple new additions to its surgical portfolios at the Association of periOperative Registered Nurses (AORN) Global Surgical Conference & Expo 2023, taking place April 1 through April 4, 2023. These innovations include the launch of the new Baxter Patient Warming system, the unveiling of the Helux Pro Connected Surgical Light, and the launch of Floseal + Recothrom flowable hemostat, all of which are on display in Baxter’s AORN booth #2027.
“Baxter takes a holistic approach to help surgical care teams navigate dynamic operating environments, providing a full suite of OR solutions that support critical decisions for patient care,” said Andrew Frye, president, Patient Support Systems/Global Surgical Solutions and Enterprise Connectivity. “We’re eager to demonstrate how our diverse portfolio of products and services can support delivering great outcomes for patients and maximizing operating room workflow efficiency.”
Products featured at AORN 2023 include the commercial launch of a new conductive Baxter Patient Warming system designed to help achieve and maintain patient normothermia (body temperature within standard limits). The system eliminates the need for disposables, as the warming technology is built into the table pad, which can reach temperatures up to 40 degrees Celsius. In addition, reusable conductive warming blankets can reach temperatures of 43 degrees Celsius and provide an increased surface warming area to help quickly warm from above and below. The system is also air-free, which may reduce risks associated with forced air systems[1]—such as contamination of the surgical site—and operates quietly. This warming solution can also be combined with WaffleGrip, a positioning accessory that helps keep the patient warm and secure in the steep Trendelenburg position, in which a patient is tilted head-down at up to a 45-degree angle. The Baxter Patient Warming system is compatible with its TS7000, TS7000dV and PST 500 surgical tables.
Baxter also revealed a first look at its Helux Pro Connected Surgical Light, a wired lighting and camera solution for the operating room. Helux Pro features deep cavity lighting, auto pattern assist technology, and a feature which helps eliminate unwanted shadows to provide consistent illumination during a surgical procedure. An included 4K camera offers ultra-high definition, reliable image capture. In addition, Helux Pro includes innovative safety features like sterile light controls and a soft exterior bumper to mitigate accidental damage. Helux Pro is expected to launch later this quarter.
Baxter’s Floseal + Recothrom is the first and only active flowable hemostat to use recombinant DNA technology. Floseal represents more than 20 years of leadership in hemostasis and has been proven to perform quickly and consistently across a range of bleeds in surgical procedures.[2] Floseal + Recothrom has a thrombin component manufactured using recombinant DNA technology, and therefore contains no human blood components and eliminates reliance on human blood donations. Together in a single product, Floseal + Recothrom has the same simple preparation[3] as Floseal + Human Thrombin but is more than 1.5 times faster[4] to prepare, which may help improve operating room efficiency. Floseal + Recothrom 5mL is currently available in the U.S. and Floseal + Recothrom 10mL will be coming later this year.
“When it comes to active hemostats in the operating room, effectiveness and speed are of critical importance given increasing patient complexity,” said Steve Wallace, president, Advanced Surgery. “The development and introduction of Floseal + Recothrom is the result of input from operating room nursing teams who prioritize fast time-to-table and ease of preparation – all areas where Floseal + Recothrom brings unique value.”
Baxter’s broad portfolio of hemostatic and sealing agents effectively work to stop bleeding in a variety of anatomies to help lower bleeding-related complications and reduce overall costs. To learn more about Floseal + Recothrom and the rest of Baxter’s Advanced Surgery portfolio, visit advancedsurgery.baxter.com.
References
1 Mehta V. Comparison of forced air and conductive heating systems during outpatient orthopedic surgeries. Journal of Anesthesia and Surgery. 2018. https://doi.org/10.15436/2377-1364.18.1771.
2 Makhija D, Rock M, Xiong Y, et al. Cost-consequence analysis of different active flowable hemostatic matrices in cardiac surgical procedures. Journal of Medical Economics. 2017;20(6):565-773. DOI:10:1080/13696998.2017.1284079.
3 Data on file – Time Motion Study – Study Number: BXU528129
4 Baxter. Data on file.
